Home

Friday, December 15, 2017 - 12:39
The addition of platelet-rich plasma (PRP) to fat grafts appears to increase longevity of the transplanted materials, but inconsistent preparation protocols make meaningful evaluation of outcomes difficult, according to a retrospective study published online in Plastic and Reconstructive Surgery—Global Open (December 6, 2017).
https://www.medestheticsmag.com/retrospective-study-examines-fat-grafting-prp
Friday, December 15, 2017 - 12:39
The addition of platelet-rich plasma (PRP) to fat grafts appears to increase longevity of the transplanted materials, but inconsistent preparation protocols make meaningful evaluation of outcomes difficult, according to a retrospective study published online in Plastic and Reconstructive Surgery—Global Open (December 6, 2017).
https://www.medestheticsmag.com/retrospective-study-examines-fat-grafting-prp
Friday, December 15, 2017 - 12:37
The U.S. Food and Drug Administration (FDA) has cleared Coolsculpting cryolipolysis treatment (Allergan) for improved appearance of lax tissue in conjunction with submental fat, or double chin, treatments. An 18-week clinical study of Coolsculpting using the CoolMini applicator for the treatment of submental fat found that 77 percent of patients showed improved appearance of lax tissue and 75 percent of patients reported their chins looked more toned following treatment.
https://www.medestheticsmag.com/coolsculpting-cleared-lax-tissue-conjunction-submental-fat

Advertisement - Box 1

Advertisement - Box 2

Friday, December 15, 2017 - 12:37
The U.S. Food and Drug Administration (FDA) has cleared Coolsculpting cryolipolysis treatment (Allergan) for improved appearance of lax tissue in conjunction with submental fat, or double chin, treatments. An 18-week clinical study of Coolsculpting using the CoolMini applicator for the treatment of submental fat found that 77 percent of patients showed improved appearance of lax tissue and 75 percent of patients reported their chins looked more toned following treatment.
https://www.medestheticsmag.com/coolsculpting-cleared-lax-tissue-conjunction-submental-fat
Friday, December 15, 2017 - 12:35
eRelevance Corporation, an automated marketing service for small- to medium-size businesses, has hired John Finocchiaro as vice president of inside sales. Finocchiaro, who will lead and continue to build an inside sales team focused on tripling sales of the eRelevance customer marketing service over the next 12 months, brings 15 years experience to the position. Most recently, he was senior manager at Dude Sales. Prior to that, he served as VP of inside sales at Knowledge Tree.
https://www.medestheticsmag.com/erelevance-announces-new-vp-inside-sales
Friday, December 15, 2017 - 12:35
eRelevance Corporation, an automated marketing service for small- to medium-size businesses, has hired John Finocchiaro as vice president of inside sales. Finocchiaro, who will lead and continue to build an inside sales team focused on tripling sales of the eRelevance customer marketing service over the next 12 months, brings 15 years experience to the position. Most recently, he was senior manager at Dude Sales. Prior to that, he served as VP of inside sales at Knowledge Tree.
https://www.medestheticsmag.com/erelevance-announces-new-vp-inside-sales

Advertisement - Box 3

Advertisement - Box 4

Thursday, December 7, 2017 - 10:44
The U.S. Food and Drug Administration (FDA) has cleared the DESCRIBE PFD Patch (Merz Aesthetics), a single-use, perfluorodecalin-infused clear patch used during laser treatment of tattoos, for all commonly used wavelengths for tattoo removal. The Patch, which is placed over tattoos prior to treatment, allows practitioners to perform rapid multiple laser passes in a single treatment session. It was previously cleared in April 2015 for use with the 755nm QS Alexandrite laser, which is effective in removal of tattoos with blue or black ink.
https://www.medestheticsmag.com/describe-pfd-patch-cleared-use-additional-wavelengths
Thursday, December 7, 2017 - 10:41
Modernizing Medicine, a provider a specialty-specific, data-driven and cloud-based electronic health record (EHR) systems, is launching two new initiatives to better support providers and patients. The company is now working with OptimizeRX, which notifies healthcare providers (HCPs) of potential prescription savings and support information for their patients, and Xcertia, a collaborative dedicated to improving the quality, safety and effectiveness of mobile health applications, or apps.
https://www.medestheticsmag.com/modernizing-medicine-launches-two-new-strategic-initiatives
Thursday, December 7, 2017 - 10:41
Modernizing Medicine, a provider a specialty-specific, data-driven and cloud-based electronic health record (EHR) systems, is launching two new initiatives to better support providers and patients. The company is now working with OptimizeRX, which notifies healthcare providers (HCPs) of potential prescription savings and support information for their patients, and Xcertia, a collaborative dedicated to improving the quality, safety and effectiveness of mobile health applications, or apps.
https://www.medestheticsmag.com/modernizing-medicine-launches-two-new-strategic-initiatives

Pages

Advertisement - Box 5

Advertisement - Box 6